Sign In
Buy PGEN
$3.81
-0.0500 (-1.30%)
At Close: Jun 03, 2026
Why NanoViricides Jumped Over 48%; Here Are 106 Biggest Movers From Yesterday
10:12am, Friday, 05'th Aug 2022 Benzinga
Gainers
ChemoCentryx, Inc. (NASDAQ: CCXI) surged 109.2% to settle at $50.43 on Thursday after the company, and Amgen, announced an agreement under which Amgen will acquire the company for $52 per sh
Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday's Mid-Day Session
05:12pm, Thursday, 04'th Aug 2022 Benzinga
Gainers
InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.
Onion Global Limited (NYSE: OG) gained 113.9% to $0.8556.
ChemoCentryx,
NeoGenomics (NEO) Expected to Beat Earnings Estimates: Should You Buy?
02:01pm, Tuesday, 02'nd Aug 2022 Zacks Investment Research
NeoGenomics (NEO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Precigen, Inc. (PGEN) to Report a Decline in Earnings: What to Look Out for
02:00pm, Monday, 01'st Aug 2022 Zacks Investment Research
Precigen, Inc. (PGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Analysts Estimate Precigen, Inc. (PGEN) to Report a Decline in Earnings: What to Look Out for
11:37am, Monday, 01'st Aug 2022
Precigen, Inc. (PGEN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Precigen, Inc. (PGEN) Upgraded to Buy: Here's What You Should Know
04:00pm, Monday, 25'th Jul 2022 Zacks Investment Research
Precigen, Inc. (PGEN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Precigen, Inc. (PGEN) Upgraded to Buy: Here's What You Should Know
01:56pm, Monday, 25'th Jul 2022
Precigen, Inc. (PGEN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Why Baker Hughes Shares Dropped 8%; Here Are 64 Biggest Movers From Yesterday
08:40am, Thursday, 21'st Jul 2022 Benzinga
Gainers
Pagaya Technologies Ltd. (NASDAQ: PGY) shares climbed 129.6% to close at $6.20 on Wednesday. Pagaya Technologies is expected to announce its Q2 earnings on August 16, 2022.
Direct Digital Ho
This Communication Services Stock Is Trading Higher By Over 82%, Here Are 45 Stocks Moving In Wednesday's Mid-Day Session
04:50pm, Wednesday, 20'th Jul 2022 Benzinga
Gainers
Direct Digital Holdings, Inc. (NASDAQ: DRCT) shares surged 82.2% to $2.6787. Direct Digital Holdings said its supply-side advertising platform, Colossus SSP, reported a 540% year-over-year gr
Apellis Pharmaceuticals, Inc. (APLS) Moves 16.3% Higher: Will This Strength Last?
11:53am, Wednesday, 20'th Jul 2022 Zacks Investment Research
Apellis Pharmaceuticals, Inc. (APLS) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there cou
This Analyst Believes Precigen's Non-Healthcare Divesture Removes Financial Overhang
12:58pm, Wednesday, 06'th Jul 2022
Yesterday, Precigen Inc (NASDAQ: PGEN) agreed to sell its non-healthcare subsidiary to URUS. HC Wainwright says they are encouraged by the divestiture of the company's non-core business and believe
Alphabet, Dyne Therapeutics And 74 Biggest Movers From Yesterday
09:21am, Wednesday, 06'th Jul 2022 Benzinga
Gainers
Enjoy Technology, Inc. (NASDAQ: ENJY) shares jumped 81.5% to close at $0.31 on Tuesday.
Rubicon Technology, Inc. (NASDAQ: RBCN) shares surged 66.1% to settle at $15.05 on Tuesday after the c
Tesla, Ra Medical Systems And 51 Stocks Moving In Tuesday's Mid-Day Session
04:05pm, Tuesday, 05'th Jul 2022 Benzinga
Gainers
Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 69.6% to $0.5240 after the company announced it has received FDA 510(k) clearance for its DABRA 2.0 catheter.
Rubicon Technology, Inc. (
Why Precigen Shares Are Gaining Today
10:57am, Tuesday, 05'th Jul 2022
Precigen Inc (NASDAQ: PGEN) has agreed to sell its subsidiary Trans Ova Genetics, an animal reproductive technologies company, to URUS, a holding company with cooperative and private ownership. The
Precigen, Inc. (PGEN) Reports Q1 Loss, Tops Revenue Estimates
10:25pm, Monday, 09'th May 2022 Zacks Investment Research
Precigen, Inc. (PGEN) delivered earnings and revenue surprises of 28.57% and 53.21%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
